Ausgewählte Publikationen

Kluin-Nelemans HC, Hoster E, Hermine O, Walewski J, Trneny M, Geisler CH, Stilgenbauer S, Thieblemont C, Vehling-Kaiser U, Doorduijn JK, Coiffier B, Forstpointner R, Tilly H, Kanz L, Feugier P, Szymczyk M, Hallek M, Kremers S, Lepeu G, Sanhes L, Zijlstra JM, Bouabdallah R, Lugtenburg PJ, Macro M, Pfreundschuh M, Procházka V, Di Raimondo F, Ribrag V, Uppenkamp M, André M, Klapper W, Hiddemann W, Unterhalt M, Dreyling MH.

Treatment of older patients with mantle-cell lymphoma.

N Engl J Med. 2012 Aug 9;367(6):520-31


Wang ML, Rule S, Martin P, Goy A, Auer R, Kahl BS, Jurczak W, Advani RH, Romaguera JE, Williams ME, Barrientos JC, Chmielowska E, Radford J, Stilgenbauer S, Dreyling M, Jedrzejczak WW, Johnson P, Spurgeon SE, Li L, Zhang L, Newberry K, Ou Z, Cheng N, Fang B, McGreivy J, Clow F, Buggy JJ, Chang BY, Beaupre DM, Kunkel LA, Blum KA.

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma.

N Engl J Med. 2013 Aug 8;369(6):507-16


Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ, Flinn IW, Flowers CR, Martin P, Viardot A, Blum KA, Goy AH, Davies AJ, Zinzani PL, Dreyling M, Johnson D, Miller LL, Holes L, Li D, Dansey RD, Godfrey WR, Salles GA.

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma.

N Engl J Med. 2014; 370(11):1008-18


Dreyling M, Ghielmini M, Marcus R, Salles G, Vitolo U, Ladetto M; on behalf of the ESMO Guidelines Working Group.

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2014 Sep;25 Suppl 3:iii76-iii82


Dreyling M; European Mantle Cell Lymphoma Network.

Mantle cell lymphoma: biology, clinical presentation, and therapeutic approaches.

Am Soc Clin Oncol Educ Book. 2014;34:191-8.


Alle in PubMed gelisteten Publikationen dieses Autors

  Verantwortlich für den Inhalt: Prof. Dr. M. Dreyling; Stand: 27.01.2015